STEPHAN DIETRICH A (President and CEO) exercised options at NEUBASE THERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 8/4/2023ACC: 0001104659-23-087887
DirectorOfficer· President and CEO
Since Jul 2019
0.00
Net shares
Net seller
$2.1K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
93.23K acquired · 93.23K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+93.23K
Price / share
$0.02
Trade value
$2.05K
% of position
New position
8/2/2023
0.00→93.23K
Total
Net shares
+93.23K
Net value
$2.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/2/2023 | M · Option Exercise | +93.23K | $0.02 | $2.05K | New position | 0.00 | 93.23K |
| Total | +93.23K | $2.05K | ||||||
Derivative Transactions1
Stock option (right to buy)
Direct
Converts to
Common Stock
93.23K shares
Shares
−93.23K
Strike price
0.022
Held after
0.00
Exercisable
—
8/2/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common Stock93.23K shares | 8/2/2023 | M · Option Exercise | −93.23K | 0.022 | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)3
Common Stock
DirectShares owned7.65K
Common Stock
DirectShares owned73.59K
Common Stock
IndirectShares owned63.69K
Total
81.24K direct·63.69K indirect144.93K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 7.65K | Direct |
| Common Stock | 73.59K | Direct |
| Common Stock | 63.69K | Indirect |
| Total | 144.93K | 81.24K direct·63.69K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported